NO924027L - Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling - Google Patents
Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO924027L NO924027L NO92924027A NO924027A NO924027L NO 924027 L NO924027 L NO 924027L NO 92924027 A NO92924027 A NO 92924027A NO 924027 A NO924027 A NO 924027A NO 924027 L NO924027 L NO 924027L
- Authority
- NO
- Norway
- Prior art keywords
- bond
- group
- preparation
- heterobia
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
Abstract
Oppfinnelsen angår heterobiarylderivater med den generelle formel R-^H - Xx - X2 - X3 - Y1 - Y2 - Y3 - Y4 - E , (I) hvor R , X til X , Y til Y4 og E har en rekke betydninger, særlig hvor R betyr hydrogen eller alkoksykarbonyl, X betyr en metylen eller -C(=NH)-, X_ betyr fenylen, X betyr en eventuelt substituert pyrimidinylen- eller pyridazinylengruppe, Y betyr en binding, -CO-, -CONH- eller -CONCH3-, Y_ betyr en binding, alkylen eller cykloheksylen, Y betyr en binding, eller en piperidinylengruppe, Y betyr en binding eller metylen, E betyr en karboksygruppe eller en alkoksykarbonylgruppe med tilsammen 2 eller 3 karbonatomer, hvorunder minst en av restene Y , Y , Y_ eller Y ikke utgjør en binding og resten E ikke kan følge umiddelbart etter et heteroatom i restene Y. eller YS, samt deres tautomerer, deres stereoisomerer, deres blandinger og deres salter, spesielt deres fysiologisk akseptable salter med uorganiske eller organiske syrer eller baser, som oppviser verdifulle farmakologiske egenskaper, fortrinnsvis aggregasjonshemmende virkninger. Fremgangsmåter for deres fremstilling er beskrevet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4134467A DE4134467A1 (de) | 1991-10-18 | 1991-10-18 | Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO924027D0 NO924027D0 (no) | 1992-10-16 |
NO924027L true NO924027L (no) | 1993-04-19 |
Family
ID=6442941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92924027A NO924027L (no) | 1991-10-18 | 1992-10-16 | Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling |
Country Status (13)
Country | Link |
---|---|
US (2) | US5418233A (no) |
EP (1) | EP0537696A1 (no) |
JP (1) | JPH05221992A (no) |
KR (1) | KR930007913A (no) |
AU (1) | AU662930B2 (no) |
CA (1) | CA2080748A1 (no) |
DE (1) | DE4134467A1 (no) |
FI (1) | FI924687A (no) |
HU (1) | HUT62272A (no) |
MX (1) | MX9205908A (no) |
NO (1) | NO924027L (no) |
NZ (1) | NZ244766A (no) |
ZA (1) | ZA927994B (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59303178D1 (de) * | 1992-04-28 | 1996-08-14 | Thomae Gmbh Dr K | Tritiumarkierte Fibrinogen-Rezeptor-Antagonisten, deren Verwendung und Verfahren zur ihrer Herstellung |
US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
PT825184E (pt) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | Derivados heterociclicos como inibidores de agregacao de plaquetas |
ZW4194A1 (en) * | 1993-03-29 | 1994-12-21 | Zeneca Ltd | Heterocyclic compounds |
DK0628550T3 (da) * | 1993-06-08 | 1998-09-28 | Vertex Pharma | Pyridazin som interleukin-1 beta-omdannede enzyminhibitorer |
GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
IL118631A (en) * | 1995-06-27 | 2002-05-23 | Tanabe Seiyaku Co | History of pyridazinone and processes for their preparation |
DE19605766A1 (de) * | 1996-02-16 | 1997-08-21 | Basf Ag | Substituierte 2-Phenylpyridine |
US6057342A (en) * | 1996-08-16 | 2000-05-02 | Dupont Pharmaceutical Co. | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
JP2001502300A (ja) | 1996-09-16 | 2001-02-20 | デュポン ファーマシューティカルズ カンパニー | ピラジノン類およびトリアジノン類およびその誘導体類 |
DE19652919A1 (de) * | 1996-12-19 | 1998-06-25 | Solvay Pharm Gmbh | Piperazinophenyl- und Piperazinophenyloxy-carbonsäure-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
AR029489A1 (es) * | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
HU228961B1 (en) * | 2000-09-18 | 2013-07-29 | Eisai R & D Man Co | Triazinones and their use as active ingredients of pharmaceutical compositions |
AR037233A1 (es) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
NZ531982A (en) | 2001-09-26 | 2005-08-26 | Kowa Co | Water-soluble phenylpyridazine derivatives and drugs containing the same as interleukin-1beta inhibitors |
DE60333733D1 (en) * | 2002-03-12 | 2010-09-23 | Shinonogi & Co Ltd | Clohexancarbonsäurederivats |
KR100469653B1 (ko) * | 2002-08-05 | 2005-02-02 | (주)동서생활건강 | 모발 컨디셔닝 고형 세정 조성물 |
US7309701B2 (en) * | 2002-11-19 | 2007-12-18 | Sanofi-Aventis Deutschland Gmbh | Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them |
FR2847253B1 (fr) * | 2002-11-19 | 2007-05-18 | Aventis Pharma Sa | Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant |
US7462613B2 (en) * | 2002-11-19 | 2008-12-09 | Sanofi-Aventis Deutschland Gmbh | Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them |
JP4960085B2 (ja) * | 2003-03-19 | 2012-06-27 | エクセリクシス, インク. | Tie−2モジュレータと使用方法 |
RU2423351C2 (ru) * | 2004-12-16 | 2011-07-10 | Вертекс Фармасьютикалз Инкорпорейтед | Пирид-2-оны, применимые как ингибиторы протеинкиназ семейства тес для лечения воспалительных, пролиферативных и иммунологически-опосредованных заболеваний |
WO2007046867A2 (en) * | 2005-05-19 | 2007-04-26 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their uses as therapeutic agents |
DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
UA103918C2 (en) | 2009-03-02 | 2013-12-10 | Айерем Элелси | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators |
ES2671748T3 (es) | 2011-07-21 | 2018-06-08 | Tolero Pharmaceuticals, Inc. | Inhibidores heterocíclicos de proteína quinasas |
WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
AU2017251537B2 (en) | 2016-04-15 | 2020-10-08 | Abbvie Inc. | Bromodomain inhibitors |
JP6964096B2 (ja) | 2016-05-25 | 2021-11-10 | バイエル ファーマ アクチエンゲゼルシャフト | 3−オキソ−2,6−ジフェニル−2,3−ジヒドロピリダジン−4−カルボキサミド類 |
JOP20190193A1 (ar) | 2017-02-09 | 2019-08-08 | Bayer Pharma AG | ممركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان |
BR112019017929A2 (pt) | 2017-02-28 | 2020-05-19 | Morphic Therapeutic Inc | inibidores de integrina (alfa-v)(beta-6) |
MA47692A (fr) | 2017-02-28 | 2020-01-08 | Morphic Therapeutic Inc | Inhibiteurs de l'intégrine (alpha-v) (bêta-6) |
EP3713931A1 (en) | 2017-11-21 | 2020-09-30 | Bayer Aktiengesellschaft | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides |
US11304946B2 (en) | 2017-11-21 | 2022-04-19 | Bayer Aktiengesellschaft | 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists |
EP3713922A1 (en) | 2017-11-21 | 2020-09-30 | Bayer Aktiengesellschaft | Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides |
WO2019101647A1 (en) | 2017-11-21 | 2019-05-31 | Bayer Aktiengesellschaft | 2-phenylpyrimidine-4-carboxamides as ahr inhibitors |
CR20210109A (es) | 2018-08-29 | 2021-06-24 | Morphic Therapeutic Inc | INHIBICIÓN DE LA INTEGRINA av ß6 |
EP3924351A4 (en) | 2019-02-12 | 2022-12-21 | Sumitomo Pharma Oncology, Inc. | FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2095240A (en) * | 1981-03-05 | 1982-09-29 | Fujisawa Pharmaceutical Co | Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
JPS58140076A (ja) * | 1982-02-09 | 1983-08-19 | Mitsubishi Chem Ind Ltd | ピリダジノン誘導体又はその塩類 |
JP3054738B2 (ja) * | 1988-07-22 | 2000-06-19 | 武田薬品工業株式会社 | チアゾロ[5,4―b]アゼピン誘導体 |
IL95548A0 (en) | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
1991
- 1991-10-18 DE DE4134467A patent/DE4134467A1/de not_active Withdrawn
-
1992
- 1992-10-14 US US07/961,135 patent/US5418233A/en not_active Expired - Fee Related
- 1992-10-14 EP EP92117507A patent/EP0537696A1/de not_active Withdrawn
- 1992-10-15 MX MX9205908A patent/MX9205908A/es unknown
- 1992-10-16 FI FI924687A patent/FI924687A/fi not_active Application Discontinuation
- 1992-10-16 HU HU9203264A patent/HUT62272A/hu unknown
- 1992-10-16 NO NO92924027A patent/NO924027L/no unknown
- 1992-10-16 AU AU27062/92A patent/AU662930B2/en not_active Ceased
- 1992-10-16 NZ NZ244766A patent/NZ244766A/xx unknown
- 1992-10-16 CA CA002080748A patent/CA2080748A1/en not_active Abandoned
- 1992-10-16 JP JP4277578A patent/JPH05221992A/ja active Pending
- 1992-10-16 ZA ZA927994A patent/ZA927994B/xx unknown
- 1992-10-17 KR KR1019920019108A patent/KR930007913A/ko not_active Application Discontinuation
-
1995
- 1995-01-19 US US08/375,084 patent/US5563268A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2080748A1 (en) | 1993-04-19 |
EP0537696A1 (de) | 1993-04-21 |
DE4134467A1 (de) | 1993-04-22 |
FI924687A0 (fi) | 1992-10-16 |
US5563268A (en) | 1996-10-08 |
AU662930B2 (en) | 1995-09-21 |
AU2706292A (en) | 1993-04-22 |
NZ244766A (en) | 1995-01-27 |
NO924027D0 (no) | 1992-10-16 |
ZA927994B (en) | 1994-04-18 |
HUT62272A (en) | 1993-04-28 |
HU9203264D0 (en) | 1992-12-28 |
KR930007913A (ko) | 1993-05-20 |
US5418233A (en) | 1995-05-23 |
MX9205908A (es) | 1993-05-01 |
JPH05221992A (ja) | 1993-08-31 |
FI924687A (fi) | 1993-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO924027L (no) | Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling | |
NO940261L (no) | 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser | |
NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
NO922940L (no) | Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem | |
MX9701305A (es) | Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas. | |
NO972881L (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
NO923466L (no) | Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser | |
NO933248L (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
NO20023161L (no) | Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem | |
AU2111992A (en) | Cyclic imino derivatives | |
EP0823423A4 (en) | 1,4-DISUBSTITUTED PIPERID DERIVATIVES | |
IL117805A0 (en) | Carbonyl piperazinyl and piperidinyl compounds | |
HU9301155D0 (en) | Methods for producing steroide derivatives and for their application in medical treatment | |
EP0526642A4 (no) | ||
WO1998008855A3 (en) | N6 heterocyclic substituted adenosine derivatives | |
NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
NO982238D0 (no) | Substituerte 4-(1H-benzimidazol-2-yl-amino)piperidiner som er anvendbare for behandling av allergiske sykdommer | |
AU1065592A (en) | Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
NO961333L (no) | Nye pyrazolderivater som angiotensin-II-antagonister | |
NO20054168L (no) | Substituerte 3-(benzoylureido)-tiofenderivater, fremgangsmate for fremstilling og anvendelse derav | |
EP1283208A4 (en) | NEW BENZOFURAN DERIVATIVES | |
Muramatsu et al. | Time-dependent interaction of a new H2-receptor antagonist, IT-066, with the receptor in the atria of guinea pig | |
IL149306A0 (en) | Benzamidine derivatives and pharmaceutical compositions containing the same | |
YU3701A (sh) | Supstituisani fenilamidini sa antitrombskim dejstvom | |
Yu et al. | Contractile effects caused by thaliporphine in the guinea-pig ileum |